Philadelphia, Pennsylvania 19104

  • Depressive Symptoms

Purpose:

This project will examine changes in metabolism and depressive symptoms after receiving CBT-I in 30 subjects with insomnia disorder and MDD.


Criteria:

Inclusion Criteria: - Insomnia Severity Index > 14 - Meet diagnostic criteria for Insomnia - Meet diagnostic criteria for Major Depressive Disorder - Either currently taking an SSRI/SNRI or no antidepressant Exclusion Criteria: - BMI > 30 - Those with unstable medical conditions defined by change in diagnosis or medication in past 2 months - Those with clinically significant comorbid psychiatric conditions (e.g., Bipolar disorder) - Those with known untreated sleep apnea or other clinically significant sleep disorder other than insomnia - Those currently taking medications that affect sleep or metabolism (e.g., stimulants, thyroid meds)


NCT ID:

NCT04719143


Primary Contact:

Paul W Gunter, M.S.
Phone: 215-746-1258
Email: paul.gunter@pennmedicine.upenn.edu


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19104
United States

Paul W Gunter, M.S.
Phone: 215-746-1258
Email: paul.gunter@pennmedicine.upenn.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 28, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.